UP!
| 2015-11-10 | Lower Price Target | Dundee Securities | $16.50 to $11.00 | |
| 2015-06-29 | Boost Price Target | Chardan Capital | Buy | $10.00 to $15.50 |
| 2015-02-18 | Initiated Coverage | Chardan Capital | Buy | $10.00 |
| 2014-08-08 | Upgrade | Ascendiant Capital Markets | Hold to Buy | $10.00 |
| 2013-12-30 | Downgrade | JMP Securities | Neutral to Underperform | $10.00 to $9.77 |
| 2013-12-30 | Reiterated Rating | Ascendiant Capital Markets | Strong-Buy to Neutral | |
| 2013-11-20 | Boost Price Target | Roth Capital | Buy | $8.00 to $9.00 |
| 2012-11-09 | Upgrade | Ascendiant Capital Markets | Buy to Strong Buy | |
| 2012-10-09 | Initiated | Ascendiant Capital Markets | Buy | $8.25 |
| 2012-04-26 | Initiated | C.K. Cooper | Buy | $11 |
| 2011-11-25 | Reiterated | Brean Murray | Buy | $9 to $7 |
| 2010-05-14 | Upgrade | Jefferies | Underperform to Hold | $10 |
| 2010-04-26 | Reiterated | Brean Murray | Buy | $11 to $14 |
| 2009-09-23 | Initiated | Brean Murray | Buy | $11 |
| 2008-10-20 | Downgrade | Citigroup | Buy to Hold | $17 to $8 |
| 2008-09-22 | Reiterated | RBC Capital Mkts | Outperform | $18 to $15 |
| 2008-09-15 | Downgrade | Robert W. Baird | Outperform to Neutral | $30 to $10 |
| 2008-04-21 | Upgrade | Broadpoint Capital | Underperform to Neutral | |
| 2008-04-18 | Downgrade | Susquehanna Financial | Positive to Neutral | |
| 2008-04-16 | Reiterated | Citigroup | Buy | $15 to $19 |
| 2008-01-16 | Reiterated | Morgan Joseph | Buy | $13 to $18 |
| 2007-10-16 | Downgrade | Broadpoint Capital | Neutral to Underperform | |
| 2007-09-07 | Reiterated | RBC Capital Mkts | Outperform | $14 to $15 |
| 2007-08-03 | Reiterated | Morgan Joseph | Buy | $24 to $13 |
| 2007-08-03 | Reiterated | BMO Capital Markets | Market Perform | $17 to $11 |
| 2007-08-03 | Downgrade | Lazard Capital | Buy to Hold |
| 2015-11-10 | Lower Price Target | Dundee Securities | $16.50 to $11.00 | |
| 2015-06-29 | Boost Price Target | Chardan Capital | Buy | $10.00 to $15.50 |
| 2015-02-18 | Initiated Coverage | Chardan Capital | Buy | $10.00 |
| 2014-08-08 | Upgrade | Ascendiant Capital Markets | Hold to Buy | $10.00 |
| 2013-12-30 | Downgrade | JMP Securities | Neutral to Underperform | $10.00 to $9.77 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In POZN 1 funds of 2213 total. Show all
| Fund name | Ticker shares |
|---|---|
| HUNTINGTON NATIONAL BANK | 1 |
| Name Relationship | Total Shares | Holding stocks |
|---|---|---|
| ADAMS ADRIAN Chief Executive Officer | 9.34% (2944888) | ACRX / ARLZ / AUXL / POZN / |
| KOVEN ANDREW I President, Chief Business Ofc. | 4.68% (1476674) | ARLZ / AUXL / KALA / POZN / |
| PLACHETKA JOHN R President, CEO and Chairman | 3.91% (1232623) | POZN / |
| Hodges William L Sr. VP Finance, CFO | 0.36% (113922) | POZN / |
| McNamara Dennis L EVP, Chief Business Officer | 0.31% (97865) | POZN / |
| LEE KENNETH B JR | 0.23% (72966) | ARLZ / BCRX / POZN / |
| Thomas Gilda Marie Sr. VP, Gen. Cnsl. & Secretary | 0.21% (67223) | POZN / |
| Kirsch Arthur S | 0.19% (58612) | ARLZ / IMMU / POZN / |
| BARNHARDT JOHN E VP, Finance and Administration | 0.17% (54388) | POZN / |
| Fowler Neal Franklin | 0.16% (50730) | ARLZ / POZN / |
| Fort John G. Chief Medical Officer | 0.16% (48901) | POZN / |
| RUDNICK SETH | 0.15% (47501) | ARLZ / POZN / SQBK / |
| Tursi James Patrick Chief Medical Officer | 0.10% (30637) | AGRX / ARLZ / AUXL / POZN / |
| Glickman Mark A Chief Commercial Officer | 0.09% (29137) | ARLZ / AUXL / POZN / |
| Charles Scott J Vice President of Finance | 0.09% (29137) | ARLZ / POZN / |
| Trachtenberg Eric Deputy General Counsel | 0.08% (25000) | ARLZ / KALA / POZN / |
| REJEANGE JACQUES | 0.07% (22200) | POZN / |
| Armstrong Jennifer Lou EVP HR and Administration | 0.07% (21853) | ARLZ / AUXL / POZN / |
| Cermak Elizabeth EVP, Chief Commercial Officer | 0.06% (20000) | POZN / |
| MAUZEY JAMES JOSEPH | 0.04% (13000) | POZN / |
| Nicklasson Martin | 0.04% (12500) | POZN / |
| Larson Angela Maria | 0.03% (8000) | POZN / |
| Bocanegra Tomas S. EVP, Development | 0.01% (4500) | POZN / |
UM